Objectives: Melancholic depression may respond differently to certain treatments. The aim of this study was to compare the antianhedonic effects of six intravenous injections of 0.5 mg/kg ketamine in patients with melancholic and non-melancholic depression, which remain largely unknown.

Methods: Individuals experiencing melancholic ( = 30) and non-melancholic ( = 105) depression were recruited and assessed for anhedonic symptoms using the Montgomery-Åsberg Depression Rating Scale (MADRS). The presence of melancholic depression was measured with the depression scale items at baseline based on DSM-5 criteria.

Results: A total of 30 (22.2%) patients with depression fulfilled the DSM-5 criteria for melancholic depression. Patients with melancholic depression had a non-significant lower antianhedonic response (43.3 vs. 50.5%, = 0.5, > 0.05) and remission (20.0 vs. 21.0%, = 0.01, > 0.05) to repeated-dose ketamine infusions than those with non-melancholic depression. The melancholic group had significantly lower MADRS anhedonia subscale scores than the non-melancholic group at day 26 ( < 0.05).

Conclusion: After six ketamine infusions, the improvement of anhedonic symptoms was found in both patients with melancholic and non-melancholic depression, and the efficacy was similar in both groups.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813595PMC
http://dx.doi.org/10.3389/fpsyt.2022.1033019DOI Listing

Publication Analysis

Top Keywords

melancholic non-melancholic
16
non-melancholic depression
16
melancholic depression
16
ketamine infusions
12
depression
12
patients melancholic
12
melancholic
9
antianhedonic effects
8
anhedonic symptoms
8
non-melancholic
6

Similar Publications

Our study aims to explore the differences in functional connectivity in the nucleus accumbens (NAc) between patients with melancholic depression and non-melancholic depression (NMD) and their relation to melancholic depression's pathogenesis. We recruited 60 melancholic depression, 58 NMD, and 80 healthy controls, all matched for gender, age, and education. Functional connectivity analysis focused on bilateral NAc as the region of interest, comparing it with the whole brain and correlating significant differences with clinical scores.

View Article and Find Full Text PDF

Aberrant high-beta band functional connectivity during reward processing in melancholic major depressive disorder: An MEG study.

Neuroimage Clin

September 2024

Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China; Nanjing Brain Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing, 210093, China.. Electronic address:

Objective: To identify the spatial-temporal pattern variation of whole-brain functional connectivity (FC) during reward processing in melancholic major depressive disorder (MDD) patients, and to determine the clinical correlates of connectomic differences.

Methods: 61 MDD patients and 32 healthy controls were enrolled into the study. During magnetoencephalography (MEG) scanning, all participants completed the facial emotion recognition task.

View Article and Find Full Text PDF

Melancholia has been proposed as a qualitatively distinct depressive subtype associated with a characteristic symptom profile (psychomotor retardation, profound anhedonia) and a better response to biological therapies. Existing work has suggested that individuals with melancholia are blunted in their display of positive emotions and differ in their neural response to emotionally evocative stimuli. Here, we unify these brain and behavioural findings amongst a carefully phenotyped group of seventy depressed participants, drawn from an established Australian database (the Australian Genetics of Depression Study) and further enriched for melancholia (high ratings of psychomotor retardation and anhedonia).

View Article and Find Full Text PDF

Neural substrates of predicting anhedonia symptoms in major depressive disorder via connectome-based modeling.

CNS Neurosci Ther

July 2024

Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.

Main Problem: Anhedonia is a critical diagnostic symptom of major depressive disorder (MDD), being associated with poor prognosis. Understanding the neural mechanisms underlying anhedonia is of great significance for individuals with MDD, and it encourages the search for objective indicators that can reliably identify anhedonia.

Methods: A predictive model used connectome-based predictive modeling (CPM) for anhedonia symptoms was developed by utilizing pre-treatment functional connectivity (FC) data from 59 patients with MDD.

View Article and Find Full Text PDF

Aberrant social reward dynamics in individuals with melancholic major depressive disorder: An ERP study.

J Affect Disord

September 2024

Department of Psychiatry, the Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China; Nanjing Brain Hospital, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing 210093, China. Electronic address:

Article Synopsis
  • Individuals with melancholic major depressive disorder (MDD) show impaired processing of social rewards compared to non-melancholic MDD patients and healthy controls, evidenced by less anticipation and blunted responses to rewards.
  • The study involved 40 melancholic MDD patients, 40 non-melancholic MDD patients, and 50 healthy controls participating in tasks measuring brain responses (ERPs) related to social rewards.
  • Findings suggest that altered social reward processing could be a potential biomarker for melancholic depression, highlighting the specific neurophysiological differences in reward perception among those affected.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!